Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol - Shinobu Shimizu; Akihito Tanaka; Nao Matsuyama; Fumie Kinoshita; Kazuhiro Furuhashi; Shoichi Maruyama (PLoS ONE, 2025)